Clinical Trial Update: 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on 18F-FSPG PET/CT imaging for patients with newly diagnosed lung cancer or indeterminate pulmonary nodules, with results posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Carcinoma
• Solitary Pulmonary Nodule

Drugs mentioned

• 18F-FSPG

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lung Carcinoma, Solitary Pulmonary Nodule | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10